Bittensor’s first token halving arrives Dec. 14, cutting TAO issuance in half as the AI-focused network adopts a Bitcoin-style fixed supply model.
You might also be interested in reading Royalty Pharma raises 2025 portfolio receipts guidance to $3.05B-$3.15B as integrated company advances biotech funding model.